Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 15.64
(0.77%)
CNY 15.64
(0.77%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.94 Million CNY | -26.48% |
| 2022 | 5.36 Million CNY | -13.38% |
| 2021 | 6.19 Million CNY | 2.9% |
| 2020 | 6.02 Million CNY | 602403400.0% |
| 2019 | 1.00 CNY | 100.0% |
| 2018 | -239.64 Million CNY | -2496.48% |
| 2017 | 10 Million CNY | -66.67% |
| 2016 | 30 Million CNY | -40.0% |
| 2015 | 50 Million CNY | -28.57% |
| 2014 | 70 Million CNY | -22.22% |
| 2013 | 90 Million CNY | 1019.51% |
| 2012 | 8.03 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 19.49 Million CNY | -48.53% |
| 2007 | 37.87 Million CNY | -32.83% |
| 2006 | 56.38 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 9.51 Million CNY | 0.0% |
| 2024 Q1 | 3.94 Million CNY | 0.0% |
| 2024 Q2 | 4.54 Million CNY | 0.0% |
| 2023 Q3 | 4.93 Million CNY | 0.0% |
| 2023 Q1 | 5.36 Million CNY | 0.0% |
| 2023 FY | 3.94 Million CNY | -26.48% |
| 2023 Q4 | 3.94 Million CNY | -20.07% |
| 2023 Q2 | 4.93 Million CNY | -8.01% |
| 2022 Q3 | 5.78 Million CNY | -8.68% |
| 2022 FY | 5.36 Million CNY | -13.38% |
| 2022 Q4 | 5.36 Million CNY | -7.25% |
| 2022 Q1 | 6.19 Million CNY | 0.0% |
| 2022 Q2 | 6.33 Million CNY | 2.27% |
| 2021 Q1 | 6.33 Million CNY | 633633200.0% |
| 2021 Q3 | 6.49 Million CNY | 1.26% |
| 2021 FY | 6.19 Million CNY | 2.9% |
| 2021 Q4 | 6.19 Million CNY | -4.59% |
| 2021 Q2 | 6.41 Million CNY | 1.26% |
| 2020 Q1 | 0.50 CNY | -50.0% |
| 2020 Q2 | 1.00 CNY | 100.0% |
| 2020 FY | 6.02 Million CNY | 602403400.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q4 | 1.00 CNY | 0.0% |
| 2019 Q2 | 1.00 CNY | 0.0% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 FY | 1.00 CNY | 100.0% |
| 2019 Q1 | 1.00 CNY | 0.0% |
| 2019 Q4 | 1.00 CNY | 0.0% |
| 2018 Q4 | - CNY | -100.0% |
| 2018 FY | -239.64 Million CNY | -2496.48% |
| 2018 Q3 | 10 Million CNY | 0.0% |
| 2018 Q2 | 10 Million CNY | 0.0% |
| 2018 Q1 | 10 Million CNY | 0.0% |
| 2017 FY | 10 Million CNY | -66.67% |
| 2017 Q4 | 10 Million CNY | -66.67% |
| 2017 Q3 | 30 Million CNY | 0.0% |
| 2017 Q2 | 30 Million CNY | 0.0% |
| 2017 Q1 | 30 Million CNY | 0.0% |
| 2016 Q1 | 50 Million CNY | 0.0% |
| 2016 Q2 | 50 Million CNY | 0.0% |
| 2016 Q4 | 30 Million CNY | -40.0% |
| 2016 Q3 | 50 Million CNY | 0.0% |
| 2016 FY | 30 Million CNY | -40.0% |
| 2015 Q4 | 50 Million CNY | -28.57% |
| 2015 FY | 50 Million CNY | -28.57% |
| 2015 Q3 | 70 Million CNY | 0.0% |
| 2015 Q2 | 70 Million CNY | 0.0% |
| 2015 Q1 | 70 Million CNY | 0.0% |
| 2014 Q1 | 90 Million CNY | 0.0% |
| 2014 FY | 70 Million CNY | -22.22% |
| 2014 Q4 | 70 Million CNY | -22.22% |
| 2014 Q3 | 90 Million CNY | 0.0% |
| 2014 Q2 | 90 Million CNY | 0.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 FY | 90 Million CNY | 1019.51% |
| 2013 Q2 | 7.79 Million CNY | 0.0% |
| 2013 Q3 | 90 Million CNY | 1055.06% |
| 2013 Q4 | 90 Million CNY | 0.0% |
| 2012 Q4 | 8.03 Million CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 FY | 8.03 Million CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2008 FY | 19.49 Million CNY | -48.53% |
| 2007 FY | 37.87 Million CNY | -32.83% |
| 2006 FY | 56.38 Million CNY | 0.0% |